Patents by Inventor Shaoqi Xi

Shaoqi Xi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Exendin 4 polypeptide fragment
    Patent number: 7608587
    Abstract: The present invention relates to an Exendin 4 polypeptide fragment, which has hypoglycemic activity, and can be used for the treatment of type II diabetes mellitus. The polypeptide sequence described herein is HGEGTX1TSDLSKQX2EEEAVX3LFIEWLKNGX4PX5, where X1 represents Phe or Tyr, X2 represents Met, Ile or Leu, X3 represents Lys, X4 represents Gly or deletion, X5 represents Arg or deletion. Additionally, the present invention relates to a method for the Exendin 4 polypeptide fragment preparation.
    Type: Grant
    Filed: August 1, 2006
    Date of Patent: October 27, 2009
    Assignee: Changzhou Pharmaceutical Factory
    Inventors: Xiaopeng Ma, Bing Wang, Shaoqi Xi
  • Exendin 4 polypeptide fragment
    Publication number: 20070037747
    Abstract: The present invention relates to an Exendin 4 polypeptide fragment, which has hypoglycemic activity, and can be used for the treatment of type II diabetes mellitus. The polypeptide sequence described herein is HGEGTX1TSDLSKQX2EEEAVX3LFIEWLKNGX4PX5, where X1 represents Phe or Tyr, X2 represents Met, Ile or Leu, X3 represents Lys, X4 represents Gly or deletion, X5 represents Arg or deletion. Additionally, the present invention relates to a method for the Exendin 4 polypeptide fragment preparation.
    Type: Application
    Filed: August 1, 2006
    Publication date: February 15, 2007
    Inventors: Xiaopeng Ma, Bing Wang, Shaoqi Xi